Andere talen SIGN THERPAR

Aandelen

SIGY

US82674U2050

Beurs gesloten - OTC Markets Andere beurzen 18:27:32 15-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
5,25 ^USD	+5,00%		0,00%	+10,99%

20/02	Sigyn Therapeutics, Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
2023	Sigyn Therapeutics, Inc. rapporteert winstresultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Sigyn Therapeutics Reports First Quarter 2024 Financial Results	15/05
Sigyn Therapeutics Discloses Publication of "Sigyn Therapy, an Emerging Candidate to Address Endotoxemia, Sepsis, and Drug-Resistant Viral & Bacterial Infections"	07/05
Sigyn Therapeutics™ to Present at Tomorrow’s Emerging Growth Conference	05/03
Sigyn Therapeutics™ Announces Filing of 2023 Annual Report on SEC Form 10-K	21/02
Sigyn Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20/02
Sigyn Therapeutics Announces Reverse Stock Split	30/01
Sigyn Therapeutics Releases Letter to Shareholders	04/01
Sigyn Therapeutics, Inc. Appoints Jerry Deciccio as Chief Financial Officer	12/12
Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial Officer	12/12
Sigyn Therapeutics Reports Third Quarter 2023 Financial Results	14/11
Sigyn Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Sigyn Therapeutics™ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment Toxicity	04-10-23
Sigyn Therapeutics to Present at Today’s Emerging Growth Conference and Tomorrow at the National Investment Bankers Association Conference	06-09-23
Sigyn Therapeutics Reports Second Quarter 2023 Financial Results	14-08-23
Sigyn Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-08-23
Sigyn Therapeutics to Present at Tomorrow’s Emerging Growth Conference	08-08-23
Sigyn Therapeutics to Present at the OTCQB Venture Virtual Investor Conference on August 3rd	31-07-23
Sigyn Therapeutics Discloses “DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES” Patent Submission and Related ImmunePrep™ Trademark Application	17-05-23
Sigyn Therapeutics, Inc. Discloses "DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES" Patent Submission and Related ImmunePrep Trademark Application	17-05-23
Sigyn Therapeutics Reports First Quarter 2023 Financial Results	16-05-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen SIGN THERPAR

Aandelen

SIGY

US82674U2050

Andere talen

Filters